JoyceFuLiuMD

Clinical Trials

• Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer Start of enrollment: 2010 Apr 14

  Active, not recruiting

  Phase 1, Phase 2

• A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer Start of enrollment: 2011 Apr 01

  Completed

  Phase 2

• A Study of BBI503 in Adult Patients With Advanced Solid Tumors Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• AO-176 in Multiple Solid Tumor Malignancies Start of enrollment: 2019 Feb 04

  Completed

  Phase 1, Phase 2

• AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma Start of enrollment: 2018 Oct 22

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2018 Dec 07

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib Start of enrollment: 2016 Nov 10

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator

• The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Start of enrollment: 2021 Feb 25

  Recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers Start of enrollment: 2023 Sep 14

  Recruiting

  Phase 1

  Roles: Principal Investigator, Contact

• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 Start of enrollment: 2023 Nov 14

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Azenosertib in Uterine Serous Carcinoma: Biomarker Study Start of enrollment: 2024 Sep 01

  Not yet recruiting

  Phase 2

  Roles: Sponsor-Investigator, Contact, Principal Investigator

• Join now to see all